After posting, I realized it was the beginning of the quarter, when institutional fund managers are doing their re-balancing acts. I'm just curious about who's investing $12m?
Yahoo charts have recently started showing bogus reverse splits. I've noticed this on several different
company's charts starting about a month ago. They are showing a 10 for 1 reverse split in January. BOGUS
6.3% last year. Minus the "special div", and it's still 3%
Date Type Amount
12/17/2014 Cash Dividends 0.5555
06/16/2014 Cash Dividends 0.6595
06/03/2014 Special Dividends 1.3604
12/18/2013 Cash Dividends 0.6514
Just put his posts on ignore....I have. Its more pleasurable to visit message boards that he lurks on now. No more sophomoric ramblings of a juvenile mind to waste time and space.......
Qualcomm Inc. (NASDAQ: QCOM) saw its short interest fall to 12.7 million shares, with 1.0 day to cover, compared to the previous period, which reported a reading of 17.7 million shares, with 1.7 days to cover. The current reading is the lowest short interest has been in the past year. The only other reading that comes close was posted after the market sell-off in October. Qualcomm shares closed Tuesday at $70.26, in a 52-week trading range of $62.26 to $81.97.
Agreed! Although my investment strategy is sector funds and ETFs. I hold very few stocks, as market sentiment, or investor activists can destroy good companies for very little reason. Before buying into Gilead the day after the plunge, I talked it over with my wife, a researcher at Pfizer, and a PFE representative in CDISC, the industry-wide group co-ordinating with the FDC. The pipeline is impressive, and hepatitis is high on eveyone's list. GILD is the major holding in my Fidelity biotech fund, and it has always looked good to me. This plunge was an opportunity not to be missed. I personally only hold six stocks, but this is one of the VERY long term holdings recently added to the portfolio. Good luck to all longs, I'm proud to say I am now among you.